Research
Hormonal
Tirzepatide, a dual GLP-1/GIP receptor agonist, produces greater weight loss (up to 21%) and superior body composition changes compared to other anti-obesity medications.
Tirzepatide is currently one of the most effective weight-loss drugs available, capable of producing ~20% weight loss. It also improves blood pressure, blood sugar, and lipid profiles. It requires weekly injections and lifestyle changes.
StrongSupportsVERY_HIGH confidence
Tirzepatide is one of the most effective anti-obesity medications tested to date. Tirzepatide not only results in approximately 20% weight loss but also improves cardiovascular risk factors...
Why this rating
Based on Phase 3 SURMOUNT trials.
Source
An Overview of Existing and Emerging Weight-Loss Drugs to Target Obesity-Related Complications: Insights from Clinical Trials
Mi-Kyung Kim et al. · Biomolecules & Therapeutics · 2024
narrative_reviewCited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →